Related content

Establishment and Characterization of a CD95 (Fas/Apo-1)-Negative Myeloma Cell Line

By  

Acta Haematologica, Vol. 101, Iss. 3, 1999-05 ,pp. : 113-118

Karger

Access to resources Recommend Favorite

Increased Expression of Fas (APO-1, CD95) on CD4+ and CD8+ T Lymphocytes during Total Body Irradiation

By  

Acta Haematologica, Vol. 104, Iss. 4, 2001-03 ,pp. : 193-196

Karger

Access to resources Recommend Favorite

Levels of soluble Fas/APO-1 in patients with Behcet's disease

By Hamzaoui K.   Hamzaoui A.   Zakraoui L.   Chabbou A.  

Mediators of Inflammation, Vol. 7, Iss. 2, 1998-04 ,pp. : 111-114

Informa Healthcare

Access to resources Recommend Favorite

Expression of Fas Ligand (CD95L) in Primary Malignant Melanoma and Melanoma Metastases is Associated with Overall Survival

By  

Oncology Research and Treatment, Vol. 29, Iss. 8-9, 2006-09 ,pp. : 361-365

Karger

Access to resources Recommend Favorite

Circadian variations do not have a major impact on serum levels of soluble (s) L-selectin (CD63L), s-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individuals

By Mosevold K. A.   Bruserud Ø.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 62, Iss. 1, 2002-02 ,pp. : 75-79

Informa Healthcare

Access to resources Recommend Favorite